retatrutide glp-3 RETATRUTIDE | NEOPEPS
Description
Development status: Pfizer's development programme for danuglipron has encountered significant challenges
This is the core group
Has 103 reviews
Most prescription medications are approved by the FDA and manufactured by drug companies
Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, Tan MH, Khan MA, Perez AT, Jacober SJ
Analytical Challenges in GLP-1 Development Despite their success, GLP-1 receptor agonists present significant analytical and development challenges
